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Abstract
Introduction: Opioid overdose deaths continue to rise. An education program focused on
immediate intervention, coined opioid education and naloxone distribution, trains
community members to properly use forms of naloxone. These programs have proven
efficacy in improving immediate overdose response.
Methods: A review of opioid education literature contains overarching themes of
methods to measure the efficacy of teaching, focusing on specific populations, teaching
requirements of the program, and lastly, information specific to homeless shelter staff.
Gaps: Gaps in the literature include the lack of accurate measurement methods, poor
generalizability of the studies, inability to ethically randomize, and lack of applicable
research in the country of the project. For future projects, education participants argue
that witnessing an overdose is a traumatic event that needs to be addressed, but minimal
adverse effects occur with the injection of intranasal naloxone. Additionally, participants
show increased acceptability of intranasal naloxone in comparison to percutaneous
methods. Lastly, to have effective naloxone projects, the accessibility of naloxone needs
to be similar to the accessibility of other lifesaving community equipment.
Keywords: opioid education, naloxone distribution, community
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A Review of the Literature: Intranasal Naloxone Teaching in Homeless Shelter Staff
Opioid overdose can occur in anyone who uses prescription opioids or illicit drugs
such as heroin, morphine, codeine, fentanyl, hydrocodone, methadone, and oxycodone
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2020b). An
opioid overdose occurs when an individual misunderstands the directions for use, if the
opioids are used illicitly or inappropriately, are prescribed for someone else, or are mixed
with other medications, alcohol, or over-the-counter drugs.
Opioid overdoses are life-threatening medical emergencies and if untreated, can
result in death. There is a correlation between those who endure poverty and
homelessness and those who use illicit drugs as a coping method (Clark et al., 2014;
McVicar et al., 2015). Between October 2019 and October 2020, a 30% increase in
opioid overdose deaths occurred in the United States (US); attributing 76 deaths to opioid
(Centers for Disease Control and Prevention [CDC], 2020).
Naloxone was approved by the Food and Drug Administration in 1971 to reverse
the toxic effects of opioids and is administered when an individual shows signs of an
opioid overdose (Boyer, 2012; SAMHSA, 2020a). Naloxone is an opioid antagonist and
works by blocking opioid receptors; it is safe and has very few adverse effects (Boyer,
2012). Naloxone can be given intramuscularly, subcutaneously, intravenously, or
intranasally and is a temporary treatment. It is essential to seek medical care postadministration as the medication can wear off quickly (SAMHSA, 2020a). Delaying the
administration of naloxone, especially in areas where emergency medical assistance has a
longer response time, can be deadly (Boyer, 2012).
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To improve immediate overdose response, opioid education and naloxone
distribution (OEND) programs have proven efficacy. Initiating and sustaining OEND
requires training community members to properly use naloxone (Clark et al., 2014). To
measure the efficacy of OEND teaching, pre-intervention and post-intervention surveys
are routinely used, including the Opioid Overdose Knowledge Scale (OOKS) and Opioid
Overdose Attitude Scale (OOAS). The overarching requirements of OEND teaching in
the literature include symptoms, prevention, risk factors, immediate action, and naloxone
administration (Clark et al., 2014).
Clinical Question
The project PICOT question guiding this literature review is: For staff at a
Midwestern homeless shelter (P) how does an opioid overdose response program (I)
compared to current practice (C) affect naloxone use and staff’s scores on an OOKS and
OOAS (O) in 3 months (T)? The objective of this paper is to discuss the literature
findings related to implementation of naloxone teaching to a homeless shelter’s staff.
Methods
A review of the literature was conducted by using the terms "opioid overdose"
AND "naloxone" AND "community" NOT prescri* on PubMed, PsychINFO, SocIndex,
CINAHL, and The Cochrane Library. These search terms and databases yielded 166
results. Articles were then excluded if they primarily addressed prescribing,
pharmacotherapeutics, or situations with trained medical personnel. Also excluded were
duplicate studies, commentaries, and articles that only provided interview results or were
provided primarily in a language other than English. Abstracts were reviewed for the
following intervention components: training, community, teaching, take-home naloxone,
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and opioid education/naloxone distribution. The articles were further narrowed by their
applicability to the project such as sample population and naloxone administration
method. A total of 21 articles included in the literature review and summarized an
evidence table (see Appendix A).
After creating the evidence table, the 21 articles were scored for level and quality
based on the John Hopkins’ Nursing Evidence-Based process (seen in Appendix B) as
can be seen in Appendix C (Dang & Dearholt, 2018). Then, each result was graded on a
quality scale. Level A must have a literature review, consistency and generalizability,
satisfactory control, and sample sizes. Level B has reasonably consistent results, a large
sample size, some definitive conclusions, reasonably consistent recommendations, and a
literature review. Grade C has little evidence, inconsistent results, small sample size, or
inability to draw significant conclusions (Dang & Dearholt, 2018). This literature review
included two IB, one IIA, two IIB, four IIIA, one IIIB, four VA, four VB, and three VC.
Studies that had a B rating were often related to unique populations or geographic groups.
Level C studies were most often defined based on their small sample sizes.
Evidence Summary
OEND
Opioid education and naloxone distribution (OEND) programs teach participants
proper administration of either intramuscular, intravenous, or intranasal naloxone and
distribute naloxone to take home at the end of the teaching (Katzman et al., 2018). The
most common alternative is the direct distribution of naloxone from area pharmacies.
Measuring naloxone usage often comes from the number of naloxone kits distributed or
self-reported usage (Bennett et al., 2018; Kirane et al., 2016). OEND teaching literature
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has the following persistent and relevant themes: quantifying efficacy, focusing on
population-specific teaching, and naloxone teaching requirements.
There are countless OEND programs in the US and many are created by each
state’s individual Department of Health. The first OEND program started in Chicago in
2001 and grew to provide naloxone to over 10,000 opioid overdoses (Lewis et al., 2017).
In 2019, 247 or 94% of survey responding OEND programs existed in syringe exchange
programs; there are also programs in homeless shelters, emergency medical services,
social services, libraries, and substance use disorder treatment programs (Lambdin et al.,
2020).
Measuring Efficacy
In the literature, post-OEND surveys have shown that after education, a range of
opioid reversals occurs throughout time. These surveys range from information
satisfaction to opinion or attitude surveys, to knowledge or competency surveys. Bennett
et al. (2018) discuss that for every person OEND-trained over a 10-year period showed
one opioid reversal. Additionally, many different types of individuals were able to
reverse multiple overdoses. Bystander training for the community supports that opioid
overdose deaths are decreased by OEND programs (Katzman et al., 2018; Naumann et
al., 2019).
In a study of 287 individuals from Bernalillo County with confirmed opioid-use
disorder, OEND and a 10-minute interview resulted in 65 overdose reversals in the
community (Katzman et al., 2019). Similarly, in a specific Los Angeles neighborhood
known for drug use, train-the-trainer naloxone teaching was administered to 66
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individuals who use intravenous opioids (Wagner et al., 2010). This training resulted in
26 opioid reversals in 18 months.
OOKS and OOAS
The OOKS assesses the knowledge that healthcare professionals, patients, and
family members have regarding overdose management (Williams et al., 2014).
Specifically, the survey discusses risk factors, observable signs and symptoms,
immediate actions, naloxone method of action and administration, adverse effects, and
post-naloxone cares (Williams et al., 2013). The survey takes 10 minutes and includes
four multiple-choice, four forced-choice, and six true/false questions. For each correct
answer, points are given.
The OOAS focuses on competence, concerns, and readiness to act for healthcare
professionals, patients, and families (Williams et al., 2013). This scale takes 15 minutes
to finish and has an alpha coefficient of 0.90. To assess content validity, the authors
compared the scores of addiction professionals to family members of opioid users; the
professionals had significantly higher scores.
Williams et al. (2014) utilized the OOKS and OOAS before, immediately after,
and 3 months after a 60-minute session. The training session included an oral and visual
presentation, an 8-minute film, hands-on demonstration, and naloxone distribution. An
increase in knowledge from baseline (31.91 correct answers) to follow-up (38.38 correct
answers) was clinically significant.
Lott and Rhodes (2016) used state Department of Health PowerPoint education to
teach about opioid overdose. Initial training showed an average knowledge level of 32.6
and immediately after, a score of 39.1. This study also exhibits that at the 3-month
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follow-up, 38.4 of the knowledge questions retained correct answers (p<0.0001). Heavey
et al. (2013) had a 90-minute OEND and utilized the OOKS and OOAS before,
immediately after, and 3 months later. An average OOKS increase of 9.7 out of 42 points
occurred, or a 23.1% improvement of scores.
Population Focus
Katzman et al. (2018) found that family and friends did not willingly attend
OEND programs because of the fear of being recognized, but those who did attend
showed the most effective increase in knowledge score. While much of the research
focuses on individuals who use opioids (Katzman et al., 2018, 2019; Kirane et al., 2016;
Leece et al., 2013; Lott & Rhodes, 2016; Madah et al., 2019; Meade et al., 2018; Wagner
et al., 2010), naloxone is not often used on the person who is taught, it is used on a third
party (Katzman et al., 2018). OEND programs can be done for support persons only
(Dahlem et al., 2016; Heavey et al., 2018; Williams et al., 2014) and can be done for a
combination of support persons and opioid users (Bagley et al., 2018; Bennett et al.,
2018; Naumann et al., 2019; Pearce et al., 2019; Wallace et al., 2018). Large-scale
naloxone distribution studies repeatedly show high satisfaction among participants but
require tailoring to the different population groups (Meade et al., 2018).
Homeless Shelter Staff
Few published articles discussed homeless shelter staff and OEND programs
(Dahlem et al., 2016; Wallace et al., 2018). Homelessness poses unique barriers to harm
reduction behaviors, including decreased access to preventative methods and confiscation
of harm reduction medication by law enforcement or homeless shelter staff (Reed et al.,
2019; Wagner et al., 2010). Reed et al. (2019) discuss that the percentage of individuals
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who carry naloxone is higher in persons who use opioids that are homeless than those
with stable housing.
Dahlem et al. (2016) utilized PowerPoint slides from the American Heart
Association as part of a statewide OEND program to teach the homeless shelter staff of
intranasal naloxone. The teaching of 40 cardiopulmonary resuscitation-trained,
nonhealthcare employees resulted in four successful opioid reversals in 3 months in
Massachusetts. Homeless shelter employees discuss that while resident overdoses are
traumatic for them, the resident endures a more traumatizing event (Wallace et al., 2018).
Homelessness is correlated with poorer alcohol and substance use outcomes than other
populations (Collins, 2016; Linton et al., 2013)
Naloxone Teaching Requirements
In a systematic review of opioid overdose prevention programs, a consensus for
naloxone education includes (1) properly identifying overdose symptoms, (2) preventing
overdose, (3) overdose risk factors, (4) immediate appropriate response, and (5) naloxone
administration (Clark et al., 2014). Other included information is often audiovisual, such
as videos (Bennett et al., 2018; Meade et al., 2018; Williams et al., 2014). Nearly all
naloxone training literature highlights the significance of education and return
demonstration. There is not a nationwide, evidence-based training in the US based on
intranasal naloxone.
OEND teaching lasts anywhere from 15 minutes (Katzman et al., 2018) to 90
minutes (Heavey et al., 2018). A variety of sessions took place, some literature shows a
single education session, some articles utilized multiple sessions for multiple weeks. All
data collection periods lasted less than a year and then were implemented long-term.
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Barriers to Layperson Naloxone Use
Access is difficult both to training and to naloxone medication for laypersons.
Lawmakers argue that allowing pharmacies to supply individuals with naloxone without
a prescription extends an individual’s life until the next overdose (Lewis et al., 2017).
There is no evidence to support the claim that providing naloxone encourages drug use.
Additionally, although some organizations provide grant-funded naloxone medication,
the cost is $100-$300 for a single-use set (Hirsch et al., 2020). Access to naloxone
without a prescription and outside of a grant-funded program only exists in CVS
pharmacies in the project state. There are only two CVS pharmacies in the project state,
and while the company claims that the medication is provided, there is no proof. (CVS
Health, 2020). Another unique, but substantial barrier is that in the US, providers do not
routinely prescribe naloxone when prescribing narcotics; nearly 70 times as many
narcotics are prescribed than are naloxone scripts (Clark et al., 2014; Lewis et al., 2017).
There is a continued, multifaceted stigma that begins with the public’s view of
individuals who deal with addiction. Public stigma focuses on stereotypes, perceived
dangerousness, and negative outlook towards individuals with opioid use disorders (Tsai
et al., 2019). When behaviors begin to occur because of the public’s stigma, enacted
stigma occurs. This includes discrimination and putting physical distance between
someone perceived to have an addiction. A combination of public and enacted stigma
leads to poor treatment access and deficient harm reduction as a society and for the
individual with addiction, disengaging from care and poor health outcomes occur. After
public and enacted stigma, structural stigma forms a major barrier. Structural stigma
causes decreased community support for laws and institutional policies. Each layer of
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stigmatization builds on the next layer, further enforcing the humiliation and
ostracization.
Gaps
Articles that discuss utilizing naloxone refill as a means for measuring overdose
reversal are likely inaccurate (Meade et al., 2018). This assumes that a single naloxone
injection was required for reversal when multiple injections could be required.
Additionally, measuring in this method does not account for naloxone that was lost,
confiscated, sold, or individuals requesting a spare dose of the medication.
Most articles discussed populations that had a male, Caucasian majority (Bennett
et al., 2018; Clark et al., 2014; Reed et al., 2019; Wagner et al., 2010; Williams et al.,
2014). Few discussed a female majority (Heavey et al., 2018; Katzman et al., 2018, 2019;
Kirane et al., 2016; Lott & Rhodes, 2016; Wallace et al., 2018) and no articles discuss
adolescents. The specific demographic population, limited population size, and little
room for generalizability put forth further areas of discussion. Further literature is needed
to discern the differences in the demographic, gender, and opioid using/non-opioid using
populations.
Many articles discuss that naloxone training is lifesaving, and randomization of
research has stopped because of the obvious observable benefit (McDonald & Strang,
2016; Meade et al., 2018). Because of the unique nature of OEND programs and the
ethical barriers to randomization, there are a climbing number of opioid prevention
programs in the US, but all programs focus on descriptive studies rather than research
(Clark et al., 2014; McDonald & Strang, 2016). Mitchell and Higgins (2016) discuss that
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research is abundant in the United Kingdom, but minimal intranasal naloxone research
exists in the US.
Recommendations for Practice
Staff members at homeless shelters argue that trauma, grief, and emotional
burdens need to be assessed after the use of naloxone (Wallace et al., 2018). Bagley et al.
(2018) discuss the importance of maintaining the anonymity of members to achieve
accurate reporting of overdose reversals. Additionally, Meade et al. (2018) discuss the
importance of tailoring the education to the audience at hand, either opioid users, support
persons, or a group of both.
Administration of intranasal naloxone shows minimal adverse effects (McDonald
& Strang, 2016; Wagner et al., 2010). Over 97.8% of suspected overdoses survived after
receiving naloxone from individuals trained through OEND programs (Bagley et al.,
2018). However, participants report minimal comfort with percutaneous injections of
naloxone and increased comfort with intranasal naloxone (Keane et al., 2018).
Katzman et al. (2019) argue that the accessibility of naloxone needs to improve to
prevent overdose deaths at a community level. Although take-home naloxone programs
have proven efficacy, McDonald and Strang (2016) argue that the administration of
naloxone is as time sensitive as using a defibrillator during cardiopulmonary resuscitation
and should be as accessible.
Conclusion
OEND literature has the following persistent themes: methods for measuring
efficacy, focusing on populations, and naloxone teaching requirements. For this project,
literature on homeless shelter staff is also included. Through these recurring themes, gaps
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and recommendations in the literature were identified. Major gaps include inaccurate
measurement of naloxone use, poor generalizability, inability to randomize, and a lack of
US-based naloxone studies. Practice recommendations include the importance of
emotional trauma follow-up after an overdose. Alternatively, minimal adverse events
occur post-intranasal naloxone injection and participants have increased comfort with
intranasal methods. The accessibility of intranasal naloxone needs to be improved to
combat the opioid overdose epidemic.
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Clark, A. K., Wilder, C. M., & Winstanley, E. L.
(2014). A systematic review of
community opioid overdose
prevention and naloxone distribution
programs. Journal of Addiction
Medicine, 8(3), 153-163.
https://doi.org/10.1097/ADM.0000000
000000034

Evidence Level,
Quality, and
Study Design

Participants,
Sample Size,
and Setting

Intervention

Results

Timefr
ame

Gaps

Comments Weaknesses

Recommendations For
Practice

Systematic
review of
qualitative
studies 2A

19 articles from
MEDLINE,
PsychINFO, and
Pubmed

Opioid overdose
prevention
program (OOPP)
from 10 minutes
to 1 hour

1949 total
successful
reversals; 83%96% survival rate;
Individuals often
use recommended
and
unrecommended
treatment
strategies
regardless of
receiving teaching.

Article
s
publis
hed
betwee
n
20012014.

Randomization of naloxone
training and administration
is likely impossible, as it
creates a major ethical
barrier to withhold lifesaving treatment.
There are 188 OOPPs in
the United States, but there
are more descriptive
studies than research.

Mostly
Caucasian men.
Focuses on only
opioid overdose
prevention
programs, not
other opioid
adverse outcome
programs.

Consensus for
education includes (1)
recognizing overdose
symptoms, (2)
preventing overdose,
(3) risk factors for
overdose, (4)
appropriate response,
and (5) naloxone
administration.
Encourages the
retesting of surveys
after several months to
consider long-term
efficacy. A convincing
indication that a
participant has
acquired
OOPP knowledge is
through the
demonstration of that
knowledge.

20 minute
teaching; 11minute video,
hands-on
demonstration,
printed material
on opioid
overdose signs
and actions, then
Naloxone kit
distribution.
Opioid education
and naloxone
distribution
(OEND).

For every person
trained each year
over the
cumulative first 10
years of the
program, there was
approximately one
overdose reversal
reported. Many
people reversed
multiple overdoses
of others. Most
reversals occurred
by opioid users.

Januar
y 1,
2006
to
Decem
ber 31,
2015

Self-reported data. Data
was obtained at a syringe
exchange program, nonPWUO do not go to these.
Most participants used
heroin, not other drugs.
A change in legislation
increased access to
naloxone during the study.
Nonrandomized, no
control.

Mostly
Caucasian men.

There is an increased
emphasis to educate
and distribute
naloxone in at-risk,
resource-deprived
individuals.
More important to
educate those who do
use opioids than those
who do not use
opioids.

Only included
original and
peer-reviewed
information.
Nonrandomized
studies.
9165 individuals
total from the
United States
and United
Kingdom

Bennett, A. S., Bell, A., Doe-Simkins, M., Elliott,
L., Pouget, E., & Davis, C. (2018).
From peers to lay bystanders: Findings
from a decade of naloxone distribution
in Pittsburgh, PA. Journal of
Psychoactive Drugs, 50(3), 240–246.
https://doi.org/10.1080/02791072.2018
.1430409

Longitudinal
Nonrandomized
Qualitative
3A

1330 opioid
users
619 support
persons
Total n=1085
Oakland,
Pittsburg
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Williams A. V., Marsden, J., & Strang, J. (2014).
Training family members to manage
heroin overdose and administer
naloxone: randomized trial of effects
on knowledge and
attitudes. Addiction, 109(2), 250–
259. https://doi.org/10.1111/add.1236
0

two-group,
parallel-arm,
non-blinded,
randomized
controlled trial
1B

adult family
members of
heroin users
versus an
informationonly control
group, with
follow-up
assessments
con- ducted
immediately
post-training
n=123
England
(London 76%,
Kent 14%,
Herefordshire
10%)

60-minute
session. Twentyfive training
sessions
Oral presentation,
8-minute film,
hands-on,
naloxone
distribution
(OEND). Utilized
OOKS and
OOAS.

The intervention
presented a greater
increase in total
opioid-related
knowledge after
the intervention,
from 31.91 (SD =
6.1) at baseline to
38.38 (SD = 4.6) at
follow-up.
There was a
substantially
greater increase in
attitudes among
the training group
[from 100.63 (SD
= 11.9) at baseline
to 114.73

2010;
interve
ntion
and
then 3
month
follow
up

Non-blinded study.

Convenience
sample is used,
Mostly
Caucasian
males.

Take-home naloxone
training for family
members of heroin
users increases opioid
overdose-related
knowledge and
competence and these
benefits are well
retained after 3
months.

Bagley, S. M., Forman, L. S., Ruiz, S., Cranston,
K., & Walley, A. Y. (2018).
Expanding access to naloxone for
family members: The Massachusetts
experience. Drug & Alcohol
Review, 37(4), 480–486. https://doiorg.excelsior.sdstate.edu/10.1111/dar.
12551

retrospective
review
3A

Massachusetts,

Opioid education
and naloxone
distribution;
monitored how
frequently they
took Narcan from
meetings.
(OEND).

total of 4373
reported rescue
attempts.
Family members
reported 860
rescue attempts or
20% of all rescue
attempts. Over
97.8% of rescued
persons survived.

2008
and
2015
Weekl
y
sessio
n

Self-reported data;
convenience sample. High
number of mothers.
Probable underreporting of
rescue attempts r/t poor
anonymity in group setting.

Geographic
restriction.

The presence of
OEND to family
members who may or
may not use drugs is
accessed by diverse
settings.
Families can take an
active position in
opioid pandemic.
Family-centered
activities should be
included in expansion
of opioid education.

network of
support groups
for the families
of people who
use opioid
23 locations
40801 total
10827 family

3

OPIOID OVERDOSE RESPONSE TEACHING TO STAFF
Madah, A. D., Gjersing, L., & Clausen, T. (2019).
Naloxone distribution and possession
following a large‐scale naloxone
programme. Addiction, 114(1), 92–
100. https://doi.org/10.1111/add.14425

Case report
5B

7 cities in
Norway
N=497 illegal
opioid users

Private 20-minute
interview.
Staff took 5-10
minutes to train
users. OEND
with THN. Two
cities were first
training, the next
five followed.
stepwise
implementation

Calculated the
number of
naloxone
injections given
4631. Naloxone
distribution
increases over
time, as the pilot
cities showed more
distribution than
subsequent cities.

June
2014 Augus
t 2017

Over-representation from
low-threshold services. All
opioid users.

Convenience
sample
Self-reported
data. Data is on
naloxone
distribution.

Earlier
implementation and
longer monitoring of
naloxone distribution
will show increased
possession of
naloxone.

Dahlem, C. H., Horstman, M. J., & Williams, B.
C. (2016). Development and
implementation of intranasal naloxone
opioid overdose response protocol at a
homeless health clinic. Journal of the
American Association of Nurse
Practitioners, 28(1), 11–18.
https://doi.org/10.1002/23276924.12249

Qualitative
study
5A

Massachusetts

PowerPoint slides
from the
American Heart
Association and
statewide OEND
chart. Done in
separate 1-2 hour
trainings. Online
anonymous
survey. Only
included
intranasal
naloxone.

4 successful opioid
reversals

April June
2013

Did not initially include
videos or simulations.

Self-reported
non-evidence
based tools used
to evaluate
teaching.

Nurse practitioners
(NP) should be on the
frontline of the opioid
pandemic both in
educating and
improving public
policy.
Intranasal naloxone is
important to have in
high-risk
organizations.

N=40
CPR‐trained
nonhealthcare
homeless shelter
staff

4

OPIOID OVERDOSE RESPONSE TEACHING TO STAFF
Wallace, B., Barber, K., & Pauly, B. B. (2018).
Sheltering risks: Implementation of
harm reduction in homeless shelters
during an overdose emergency. The
International journal on drug
policy, 53, 83–89.
https://doi.org/10.1016/j.drugpo.2017.
12.011

Qualitative
5C

Naumann, R. B., Durrance, C. P., Ranapurwala,
S. I., Austin, A. E., Proescholdbell, S.,
Childs, R., Marshall, S. W., Kansagra,
S., & Shanahan, M. E. (2019). Impact
of a community-based naloxone
distribution program on opioid
overdose death rates. Drug and
Alcohol Dependence, 204.
https://doi.org/10.1016/j.drugalcdep.2
019.06.038

Empirical
quantitative
study
3A

Kirane, H., Ketteringham, M., Bereket, S., Dima,
R., Basta, A., Mendoza, S., Hanssen,
H. (2016). Awareness and attitudes
toward intranasal naloxone rescue for
opioid overdose prevention. Journal of

Cross-sectional;
quantitative
5A

N=49
Victoria, Canada

40-60-minute
recorded focus
groups led by
well-trained
researchers.
Utilized
interpretive
description to
discuss their
views on
overdose and the
homeless
shelters’
preparedness.

Although staff
faces trauma when
experiencing a
resident’s
overdose, the
resident
experiences trauma
that is life
threatening. The
trauma, grief, and
emotional burdens
need to be assessed
after the need to
use naloxone.
Homeless shelters
are microenvironments that
are breeding
grounds for opioid
overdose.
Overdoses often
occurred in
bathroom because
there wasn’t a
“safe space” to
use.

Decem
ber,
2015
to
Januar
y,
2016

-Two shelters in a single
city.
Does not include homeless
individuals who choose not
to shelter.
Subjective experiences.

Financial
incentives to
staff and
residents.
A third of
shelter residents
were indigenous
and most were
women.

The only study that
includes staff at lowbarrier shelters that do
not require abstinence
from drugs/alcohol.
Incomplete harm
reduction
implementation
strategies can lead to
misconceptions of
staff and of residents.

38 different
counties in
North Carolina

Provided
naloxone kits and
measured the
refill number.
Distributed
39,449 naloxone
kits across NC.
Discusses cost
benefit.

352 NC deaths
were avoided by
naloxone
distribution (95%
CI: 189, 580). On
average, for every
dollar spent on the
program, there was
$2742 of benefit
due to OODs
avoided (95% CI:
$1,237, $4882).

Augus
t 2013
to
Decem
ber
2016

Restricted to counties with
already high opioid
overdose deaths.
Financial benefit could be
different in different states.
Rural counties were not
included.
It is assumed that one kit’s
use resulted in one reversal,
which is not necessarily
true.

Focuses on costbenefit of takehome naloxone
in at-risk
communities.

Community-based
opioid overdose deaths
are decreased by
naloxone distribution.
Healthcare personnel
and community
members need to
continue to advocate
for widespread
naloxone distribution.

Single large
community
hospital on
Staten Island

Interview/ selfadministrated
surveys. Derived
from, but not
exactly like

50% of providers
felt naloxone
access would
decrease the
likelihood of an

Six
month
s;
Augus
t 2014

small sample size, single
geographic location,
convenience sampling, the
distinct demographics of
the patients, and the

Mostly
Caucasian
males. Includes
only patients
who have been

Routine follow-up of
survey questions is
necessary in
determining the
efficacy of teaching.

Low barrier
shelter residents
(n = 23), shelter
staff (n = 13),
and harm
reduction
workers (n =
13).
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Substance Abuse Treatment, 69, 4449.
https://doi.org/10.1016/j.jsat.2016.07.0
05

N=101
18% of
participants are
homeless

opioid Overdose
Knowledge Scale
(OOKS) and the
Opioid Overdose
Attitude Scale
(OOAS)

overdose
occurring, and
58% felt it would
not contribute to
high-risk behavior.
Among providers,
completion of
naloxone training
was correlated
with increased
awareness of
where to access
kits for patients (p
< 0.001)

to
Januar
y 2015

distinctive clinical setting
of substance abuse
detoxification and
rehabilitation programs,
and an emergency
department. Not able to
generalize. Did not assess
prior naloxone knowledge.

treated for
opioid/substance
abuse.
Although it’s
based on an
evidence-based
scale, it’s not
validated or
reliable.

Education was
adapted from the
New York State
Department of
Health’s Opioid
Overdose
Prevention
Guidelines for
Training
Responders by
summarizing it in
a 23slide slideshow.
The session
follows a
group format
with lecture,
slideshow, and
handout and
provides
recognizing signs
of opioid
overdose and use
of naloxone.
Patients were
able to ask
questions during
and after the
presentation, and
the entire

Utilized the OOKS
prior, immediately
after, and 3 months
after. Significant
improvement in
scores from the
OOKS following
the education from
32.6 to
39.1 (p < .0001),
which was mostly
retained at the
follow-up
time point (total
score of 38.4). The
OOKS subdomains
Actions and
Naloxone Use
followed a similar
pattern
(p < .0001).

3
month
s of
monito
ring in
2015,
compa
red to
histori
cal
control
in
2011.

There were no changes
between the intervention
and control, suggesting that
spending time discussing
the medication is effective.
Not randomized.
Relatively low follow-up
rate.
Historical control.

Mostly
Caucasian
males. $5 gift
card incentive.
Specific
geographic
region.

inpatient
detoxification

Lott, D. C., & Rhodes, J. (2016). Opioid overdose
and naloxone education in a substance
use disorder treatment program. The
American Journal on Addictions,
25(3), 221–226. https://doiorg.excelsior.sdstate.edu/10.1111/ajad.
12364

Qualitative
2B

N=43
Opioid addicts
at community
addiction
treatment center
in New York

Treatment seekers and
at risk-individuals are
important cohorts to
teach OOPP.
Education alone is not
effective enough to
exhibit change,
distribution of
naloxone is necessary.
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session was 30–
45 min

Pearce, L. A., Mathany, L., Rothon, D., Kuo, M.,
& Buxton, J. A. (2019). An evaluation
of take home Naloxone program
implementation in British Columbian
correctional facilities. International
Journal of Prisoner Health, 15(1), 46–
57. https://doiorg.excelsior.sdstate.edu/10.1108/IJP
H-12-2017-0058

Qualitative
5A

United Kingdom
correctional
facilities
N= 1318
Clients=n=35

Train-the-trainer
OEND with
THN. Focused
interviews with
drug users,
family/friends,
and
staff/volunteers.
One-hour
training, 20minute to 1-hour
interview.

836 kits dispensed,
59 kits used. 66
opioid reversals
most were by a
third party at a
private residence
who used heroin.

Nov
2012June
2013

Opioid users did not often
call 911.
No systematic follow-up.
Subjective experiences.
Kits were confiscated by
police.
Convenience sample.
Ungeneralizable.

Very specific
population.

The importance of
tailoring education to
unique population
groups.

Meade, A. M., Bird, S. M., Strang, J., Pepple, T.,
Nichols, L. L., Mascarenhas, M.,
Choo, L., & Parmar, M. K. B. (2018).
Methods for delivering the UK’s
multi-centre prison-based naloxoneon-release pilot randomised trial (NALIVE): Europe’s largest prisonbased randomised controlled
trial. Drug and Alcohol Review, 37(4),
487–498. https://doiorg.excelsior.sdstate.edu/10.1111/dar.
12592

Initially
randomized
control trial;
turned
qualitative
3B

16 Correctional
facilities (adult
prisoners)
United Kingdom
N= 1685
prisoners (842
naloxone; 843
control

N-ALIVE
instructional
DVD; in person
training and takehome naloxone

A third of the
emergency
naloxone
administrations to
reverse overdose
were to the
randomized exprisoner,
two-thirds were to
an individual who
was not the study
subject.

Februa
ry
2011Decem
ber
2014

Randomization was
stopped because the
naloxone was often being
used on someone other
than the ex-prisoner. The
naloxone was then given to
all participants on release
from the correctional
facility.

Very specific
population.

Large scale naloxone
take-home studies
show high satisfaction
among consumers.
Take home naloxone
studies are unethical to
randomize, as it is lifesaving treatment. The
importance of tailoring
education to unique
population groups.

McDonald, R., & Strang, J. (2016). Are take‐
home naloxone programmes effective?
Systematic review utilizing application
of the Bradford Hill criteria.
Addiction, 111(7), 1177–1187.
https://doiorg.excelsior.sdstate.edu/10.1111/add.
13326

Systematic
review of
qualitative
studies 2B

22 studies
included from
MEDLINE,
PsycINFO, and
PubMed

Assessed articles
via the Bradford
Hill Criteria for
(1) strength of
association,
(2) consistency,
(3) specificity, (4)
temporality, (5)
dose–
response
relationship, (6)

in control
communities that
did not implement
THN, opioid
overdose mortality
was significantly
higher. Providers
argue that take
home naloxone is a
gateway for heroin
users, and

Januar
y 1946
and
June
2015

Data is based off of
naloxone refill, which
might not be the most
accurate measure of
naloxone administration.
Positive naloxone
outcomes are likely to
create biased, positive
satisfaction scores in
naloxone users.

No articles were
randomized.
There is no true
experimental
data, as it is
considered
unethical.

Time delivery of
naloxone is crucial
and is compared to
public placement of
defibrillators and
teaching of
cardiopulmonary
resuscitation for lay
people likely to
witness a cardiac
arrest.
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plausibility, (7)
coherence, (8)
experimental
evidence and (9)
analogy.

encourages use but
this is not
supported in the
evidence.
Improved survival
rates and reduced
mortality rates.
Low number of
adverse effects.

Take home naloxone
has proven efficacy in
heroin overdose but
needs further research
in opioid and
methodone overdose.

Wagner, K. D., Valente, T. W., Casanova, M.,
Partovi, S. M., Mendenhall, B. M., Hundley, J.
H., Gonzalez, M., & Unger, J. B. (2010).
Evaluation of an overdose prevention and
response training programme for injection drug
users in the Skid Row area of Los Angeles, CA.
International Journal of Drug Policy, 21(3), 186–
193. https://doiorg.excelsior.sdstate.edu/10.1016/j.drugpo.2009.0
1.003

Observational
5A

Specific
neighborhood in
Los Angeles,
CA
Only IV drug
users
N=66

Training sessions
were conducted
individually or in
small groups (two
to six people) by
two trainers. Both
were educated in
overdose
prevention and
response training
through local
overdose
prevention efforts
and a “Train the
Trainer” seminar.
Discussion and
slides and handson. Provided
intramuscular
naloxone kits
OEND.

Thorough incident
reporting with
naloxone refill.
The proportion of
victims who died
at the scene was
similar before
(9%) and after
(11%) the training.
However,
important changes
in knowledge,
attitudes, and
response behaviour
were observed.
53% of
participants
reported decreased
drug use at followup which
contradicts the
belief that
naloxone training
encourages drug
use. 26 successful
opioid reversals.

Septe
mber
2006Januar
y 2008

Financial incentives for
completing initial and
follow-up. Several reports
of loss, theft, or
confiscation of naloxone
compared to other studies.
No control group, no
randomization. Relies on
self-reports.

Very specific
geographic
location. Mostly
male, homeless
population.
Mixed racial
groups.

This training in
intravenous drug users
shows change
behavior and selfefficacy.
There are few negative
consequences.

Reed, M., Wagner, K. D., Tran, N. K., Brady, K.
A., Shinefeld, J., & Roth, A. (2019). Prevalence
and correlates of carrying naloxone among a
community-based sample of opioid-using people
who inject drugs. International Journal of Drug
Policy, 73, 32–35. https://doiorg.excelsior.sdstate.edu/10.1016/j.drugpo.2019.0
7.010

Qualitative case
study
5A

Philadelphia,
PA
Used drugs in
the last 12
months.
n = 571

Government
funded survey
based off of a
single question
and demographic
questions.

Odds of carrying
naloxone were
higher among
PWID who were:
homeless in the
past year.

2015

Financial
incentives/recruitment.
Cross sectional study of
one city. Miscommunicated
question.

Mostly
Caucasian
males.

Homelessness and law
enforcement
encounters are known
barriers to harm
reducing behaviors.
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Katzman, J. G., Greenberg, N. H., Takeda, M. Y.,
& Moya Balasch, M. (2019). Characteristics of
patients with opioid use disorder associated with
performing overdose reversals in the community:
An opioid treatment program Analysis. Journal
of Addiction Medicine, 13(2), 131–138.
https://doiorg.excelsior.sdstate.edu/10.1097/ADM.0000000
000000461

Mitchell, K. D., & Higgins, L. J. (2016).
Combating opioid overdose with public access
to naloxone. Journal of Addictions Nursing, 27,
160-179.
https://doi.org/10.1097/JAN.000000000000013
2

Qualitative
cohort.
5B

N=287
Confirmed
opioid use
disorder.
Bernalillo
County, New
Mexico

Education for OD
recognition and
response.
Instructed on
"Evzio," and
demonstrated
proper kit use to
the study
coordinator. At
the end of the
enrollment visit,
1 naloxone autoinjector kit was
given to each
participant and
instructed to
teach their
household. Study
participants
engaged in a 10to 15-minute
follow-up
interview at both
3 and 6 months to
asses any new
experiences with
opioid ODs since
study enrollment

65 OD reversals in
the community.

6
month
s
April
4 and
Octob
er 5,
2016

Most individuals were
younger than 30 years old.
Data is self-reported. 38
naloxone kits were lost or
stolen.

Most enrollees
at the
organization
used are women
(71%). Hispanic
white is
dominating race.
Does not assess
the knowledge,
thoughts, or
feelings of the
individual.

If naloxone is
accessible, more
patients treated in an
OTP setting can
perform OD reversals
in the community.
Success is dependent
on social connectivity.

Meta-analysis of
qualitative
research
3A

38 articles from
Academic
Search Premier,
CINAHL
Complete,
MEDLINE
Complete,
PubMed, and
Psychology and
Behavior

Articles focused
on global trends,
U.S. OEPs with
naloxone
distribution,
barriers to
naloxone
distribution,
political
opposition and

Many articles
discuss IV heroin
users, not many
articles discuss
oral opioid users.
Most populations
are high-risk drug
users already.

20102016

Authors only gathered
information about overdose
reversals if participants
returned for naloxone
refills, which could
underestimate the results.
articles were inconsistent in
focus regarding target
patient populations

There is a lack
of information
in the United
States,
abundance of
research in the
United
Kingdom.

Nursing is
underrepresented in
nursing literature, but
poses a unique
vantage point.
Nurse practitioners are
fundamental in
education,
management, and
evaluation of
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Keane, C., Egan, J. E., & Hawk, M. (2018).
Effects of naloxone distribution to
likely bystanders: Results of an agentbased model. International Journal of
Drug Policy, 55, 61–69. https://doiorg.excelsior.sdstate.edu/10.1016/j.drug
po.2018.02.008

Qualitative
5C

Katzman, J. G., Takeda, M. Y., Bhatt, S. R.,
Balasch, M. M., Greenberg, N., & Yonas, H.
(2018). An innovative model for Naloxone use
within an OTP setting: A prospective cohort
study. Journal of Addiction Medicine, 12(2),
113–118. https://doiorg.excelsior.sdstate.edu/10.1097/ADM.0000000
000000374

Prospective
qualitative study
5B

Sciences
Collection.

support, and
financial impact.

Providers=n=7
Clients=n=22

Descriptive
interviews that
lasted 45-60
minutes and
simulations with
real-life
situations.
Community
based naloxone
distribution.

No comfort with
injectable forms of
naloxone.
Decreased opioid
overdose deaths in
simulated
community.

July
throug
h
Septe
mber
2016

Simulated experience, no
real data.
It was assumed that one
naloxone dose would result
in one opioid reversal but
this is not necessarily true
related to high dose
fentanyl and other synthetic
drugs.

Small sample
size.
Restricted
geographic area.
Financial
incentives.

Need increase support
for naloxone
distribution via harm
reduction sites, such as
syringe exchange
programs, since these
sites are more likely to
engage people at high
risk for overdose
deaths, that is, people
who use opioids.
Given that overdoses
in which fentanyl is
present are on the rise,
efforts to ensure
adequate availability
of naloxone as well as
to develop and
distribute sustainedrelease forms of
naloxone will be
critical.

15-20 minutes of
teaching and
participant
demonstration
with naloxone
distribution
(OEND).

38 opioid reversals
in three months
(13%).

April
4,
2016
and
July 4,
2016

Because of the Health
Insurance Portability and
Accountability Act, direct
outcome assessment of the
com- munity members who
were treated with naloxone
for an overdose reversal
was not possible.
Many people survive
overdose from heroin and
prescription opioid pain
relievers without naloxone
or EMS support.

Mostly women
(71%) and
includes
pregnant
women.
High percentage
of methadone
users.

Naloxone is not often
used on the person
who is taught, it is
used on a third party.
Community and
bystander training
shows proven ability
to use appropriately in
the community.

Urban
Southwestern
Pennsylvania

N=244
New Mexico
addiction center

layperson naloxone
use.
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Heavey, S. C., Burstein, G., Moore, C., &
Homish, G. G. (2018). Overdose education and
naloxone distribution program attendees: Who
attends, what do they know, and how do they
feel? Journal of Public Health Management &
Practice, 24(1), 63–68. https://doiorg.excelsior.sdstate.edu/10.1097/PHH.00000000
00000538

Qualitative
5C

Leece, P. N., Hopkins, S., Marshall, C., Orkin,
A., Gassanov, M. A., & Shahin, R. M. (2013).
Development and implementation of an opioid
overdose prevention and response program in
Toronto, Ontario. Canadian Journal of Public
Health, 104(3), e200-4.
https://doi.org/10.17269/cjph.104.3788

Qualitative
5B

Erie County,
New York
N=198

N=209
Toronto needle
exchange
program

90-minute
education session
and naloxone
distribution
(OEND). OOKS
and OOAS.

Knowledge scores
improved across
all training
sessions, with an
average score
increase of 9.7 out
of 42 points, a
23.1% increase (P
< .001). Average
increase of 15.4%.

Octob
erNove
mber
2015

Did not track naloxone kit
use.
Poor distribution of opioid
users.

Mostly
Caucasian
(84%) and
females (77%).

Family and friends
show decreased
OEND attendance
related to
embarrassment or
worry of being
recognized.
OEND programs
effectively reach
family/friends but not
necessarily opioid
users.

20-minute
individual or
small group
education. IM
naloxone
injection called
POINT training
(OEND).

17 successful
opioid reversals.
Trainers report that
intranasal
naloxone would be
more user friendly
and easier to teach.
Successful
recruitment.

8
month
s.
Augus
t 2011

Technically less reversals
than other studies.

Only targets
opioid users.
Takes place in a
different country
with possibly
different laws.
Intranasal
naloxone not
legal in Canada.

Other public health
organizations could
benefit from this
teaching method.
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Appendix B: Evidence Level and Quality Guide
Level 1: experimental study, randomized

A= High quality

controlled trial, systematic review of

B= Good quality

randomized controlled trials (RCTs)

C= Low quality or major flaws

Level II: Quasi-experimental study,
systematic review of quasi-experimental
and RCTs
Level III: non-experimental, systematic
review with a combination of studies,
qualitative study
Level IV: opinion of respected persons or
panels
Level V: based on experiential, not
research

1

2
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Appendix C: Level of Evidence and Grade Table
Levels of Evidence
Level I

Level II

Level III

Level IV

Level V

Quality of Evidence
2

3

5

0

11

A

0

B

2

C

0

A

1

B

2

C

0

A

4

B

1

C

0

A

0

B

0

C

0

A

4

B

4

C
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Abstract
Background/Purpose: Opioid overdose can occur in anyone who uses illicit drugs, but
relationship correlation exists between homelessness and illicit drug use. Between March
2019 and March 2020, 92 deaths were attributed to opioids in the DNP Project state.
Methods: Naloxone education was given to a single population of homeless shelter staff.
An Opioid Overdose Attitude Scale (OOAS) and Opioid Overdose Knowledge Scale
(OOKS) were administered to the sample prior to education, immediately after education,
and 3 months after education.
Results: OOAS and OOKS changes between surveys as a whole were not statistically
significant (p=0.14; p=0.25). Individual components of the surveys did show statistical
significance. OOKS pre-education and immediate post education risk and naloxone
questions were statistically significant (p=0.03, p=0.02). OOAS competency for preeducation to immediate post-education (p=0.00075) and pre-education to 3-month post
(p=0.017) was statistically significant.
Discussion: This specific statewide naloxone program showed an increase in baseline
knowledge and a sustained increase in survey scores over time. This indicates that the
teaching method is effective in certain areas but requires tailoring to the specific audience
to improve efficacy of the education.
Implications for Practice: This DNP Project has the potential to equip high-risk
environments with lifesaving treatment.
Keywords: homeless shelter staff, opioid education, naloxone distribution
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Opioid Overdose Response Teaching to Staff in a Homeless Shelter
Background/Purpose
Opioid overdose can occur in anyone who uses illicit drugs, but there is a
relationship between being homeless and using illicit substances as a coping mechanism
(Clark et al., 2014; McVicar et al., 2015). Naloxone is administered when an individual
shows signs of an opioid overdose such as pallor, clamminess, unresponsiveness,
pinpoint pupils, cyanosis, vomiting, shallow breathing, or absent pulse (Substance Abuse
and Mental Health Services Administration [SAMHSA], 2020). The World Health
Organization (2018) suggests availability of naloxone to people that are likely to witness
an overdose, including individuals who use opioids, their friends, and families.
Significance of the Problem
In the Midwestern state that the DNP Project occurred, between March 2019 and
March 2020, 92 deaths were considered opioid overdoses (Centers for Disease Control
and Prevention [CDC], 2020a). In 2018, the opioid overdose death rate was 6.9 per
100,000 (CDC, 2020b). Although many naloxone distribution programs exist in syringe
exchange programs, the project state does not have any publicly acknowledged syringe
exchange programs (North American Syringe Exchange Network, 2020). Out of the 66
counties in the project state, 22 (33%) report a history of or current naloxone distribution
program.
Opioid overdose survivors have experienced a traumatic event that is not only
physically taxing, but also requires adjustment to emotional consequences of overdosing
such as embarrassment, guilt, rage, and appreciation (SAMHSA, 2018). The individual
who had the overdose is not the only individual affected by the event as family members,
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friends, and support persons often feel scrutinized or helpless because they believe they
could have prevented the overdose. The impact of an overdose expands to communities,
as opioid overdoses are not always private, in-home events.
PICOT Question
The PICOT question that guided this DNP Project was: For staff at a Midwestern
homeless shelter (P) how does an opioid overdose response program (I) compare to
current practice (C) affect the number of naloxone kits used and staff’s scores on an
OOKS and OOAS (O) in 3 months (T)?
Evidence Findings
Opioid education and naloxone distribution. Opioid education and naloxone
distribution (OEND) programs teach participants proper naloxone administration and
distribute naloxone to take home (Katzman et al., 2018). There are many OEND
programs in the United States (US) that are created by each state’s individual Department
of Health. There are OEND programs in homeless shelters, emergency medical services
(EMS), social services, libraries, syringe exchange, and substance use disorder treatment
programs (Lambdin et al., 2020).
Through a systematic review of opioid overdose prevention programs, a
consensus for naloxone education includes (1) properly identifying overdose symptoms,
(2) preventing overdose, (3) reducing overdose risk factors, (4) activating immediate
appropriate response, and (5) naloxone administration (Clark et al., 2014). Nearly all
naloxone training literature emphasizes the importance of instruction and return
demonstration. A nation-wide, evidence-based intranasal naloxone training program does
not exist in the US. At a community level, opioid overdose deaths are decreased by
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OEND programs and bystander training shows proven efficacy in naloxone use (Katzman
et al., 2018; Naumann et al., 2019).
Population focus and homelessness. Large-scale naloxone distribution studies
repeatedly report high satisfaction among participants but require population tailoring
(Meade et al., 2018). Homelessness poses unique barriers to harm reduction behaviors
(Reed et al., 2019; Wagner et al., 2010). Homeless shelters are micro-environments that
frequently experience overdoses. Homeless shelter staff spend time and many live within
the same facility as the residents; this increases their presence as support persons.
Additionally, homeless individuals have worse alcohol and substance use outcomes than
other populations (Collins, 2016; Linton et al., 2013)
Barriers to Layperson Naloxone Use
Access is difficult for both training and obtaining naloxone for laypersons.
Although some grants allow for access to free naloxone, the lifesaving treatment costs
$100-$300 for a single-use kit (Hirsch et al., 2020). There is a continued, multifaceted
stigma that begins with the public’s view of individuals who deal with addiction. Public
stigma focuses on stereotypes, perceived dangerousness, and negative outlook towards
individuals with opioid use disorders (Tsai et al., 2019).
Gaps
Further literature is needed to discern the differences in the demographic, gender,
and opioid-using/non-opioid using populations. Many articles discuss naloxone training
as lifesaving, and research studies have stopped randomization because of the obvious
perceived benefit of the training (McDonald & Strang, 2016; Meade et al., 2018).
Because of the unique nature of OEND programs and the ethical barriers to
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randomization, there are climbing numbers of opioid prevention programs in the US, but
all programs focus on descriptive studies rather than research (Clark et al., 2014;
McDonald & Strang, 2016). Mitchell and Higgins (2016) discuss that research is
abundant in the United Kingdom, but minimal intranasal naloxone research is available in
the US.
Recommendations for Practice
Staff members at homeless shelters argue that trauma, grief, and emotional
burdens need to be assessed after the use of naloxone (Wallace et al., 2018). Additionally,
Meade et al. (2018) discuss the importance of tailoring the education to the audience at
hand, either opioid users, support persons, or a group of both. Administration of
intranasal naloxone shows minimal adverse effects (McDonald & Strang, 2016; Wagner
et al., 2010). Over 97.8% of suspected overdoses survived after receiving naloxone from
individuals trained through OEND programs (Bagley et al., 2018). Participants report
minimal comfort with percutaneous injections of naloxone and increased comfort with
intranasal naloxone (Keane et al., 2018).
Methods
A change theory guides and structures the DNP Project process. This was
accomplished through using Barrett’s Theory of Power as Knowing Participation in
Change as a guide (Barrett, 2015). This theory focuses on an individuals’ awareness,
choice, freedom to act purposefully, and involvement in change as a positive change
determination. A depiction of Barrett’s theory can be seen in Appendix C.
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model was used
as a guide for this DNP Project. A depiction and permission to use this model can be seen
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in Appendix D. JHNEBP is an evidence-based method of identifying the need for and
implementation of change (Dearholt, 2012). First, the clinical practice question is created,
and a literature review is completed, appraised, and synthesized. Lastly, evidence-based
change translation is outlined and put into practice.
Hildegard Peplau’s (1952) nurse-client relationship was used as a guide to foster a
relationship between the student and homeless shelter staff. The orientation phase is
initiated by the nurse and focuses on evolving trust. Next, identification of workplace
problems is recognized, and the client-patient pair begin working independently, with the
nurse as the resource. Lastly, once goals have been met, information is summarized, and
the relationship is typically terminated.
Sample
Staff in the homeless shelter are of many employment statuses, training, varying
ages, education, genders, and experience with homeless populations. Participant
demographic information was obtained through a survey (see Appendix E). Specific data
from the demographics survey can be seen in Appendix F. A total of 14 individuals
participated in the project. The number of staff members employed full-time was 11
(78.6%) and part time was 3 (21.4%). The majority of participants had less than a year of
experience working with the homeless population. Although 20 individuals participated
in the teaching, the sample size was 14 as two employees rotated in and out of the
teaching session to check on residents and four individuals participated via Zoom. These
participants were excluded because they did not have access to the surveys and were not
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able to be checked off on return demonstration; however, they received the same
naloxone education.
Setting
The DNP Project setting was a non-profit, low-barrier homeless shelter in the
Midwestern US. Low-barrier shelters do not allow guests to ingest drugs or alcohol on
the premises, but guests are not turned away if they appear under the influence (US
Interagency Council on Homelessness, 2018). Since 2015, the homeless shelter has had
80 male beds, 20 female beds, and seven family rooms. The homeless shelter provides
emergency nighttime shelter. Additionally, this homeless shelter has clinical hours for
mental health and addiction counseling. The homeless shelter houses on average 100
guests and seven families per night, and an additional 20-40 people, including children
(M. Shields, personal communication, October 8, 2020).
Current practice for a suspected opioid overdose included notifying EMS by
calling 911. A naloxone policy did not exist, staff were not trained on identification and
administration of naloxone. Additionally, staff were not regularly educated on signs of
opioid overdose in the proposed DNP Project setting.
Evidence Based Interventions
The education and in-person educator were state-selected and state-funded.
Education was created by the State’s Department of Health as a component of a statewide
Naloxone Project (see Appendix G). The PowerPoint included statistics of opioid
overdoses, a discussion on how opioids work, signs and symptoms of overdose, and
appropriate opioid overdose treatment response, as is encouraged through the literature
(Clark et al., 2014). First, state-specific statistics and naloxone legislation were discussed
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including immunity from civil liability for the staff member and the organization. This
exists when the staff is acting in good faith and with compliance to the naloxone
administration protocol. The PowerPoint discussed that opioids work by acting on
receptors in the brain that relieve pain, but also slow down breathing and could lead to
death if used inappropriately.
The education detailed steps for staff that witness an opioid overdose.
Additionally, staff were educated that there is a difference between a shelter resident that
is under the influence of drugs and in a state of emergency. When a shelter resident is
unresponsive to sternal rub, breathing less than 10 breaths per minute, and/or gasping or
choking, staff is to follow the protocol (see Appendix H). This protocol does not occur if
the shelter resident does not meet any of the previously listed criteria. This list of actions
in the protocol all need to occur, but can occur simultaneously, and not necessarily in any
specific order. The steps include: move bystanders from the area to provide privacy with
screens or blankets; notify EMS; assess resident’s qualification for intranasal naloxone;
put on gown, gloves, and mask with face shield; administer intranasal naloxone; and
begin cardiopulmonary resuscitation if needed or place client in the recovery position.
Surveys for Comprehension
The Opioid Overdose Attitudes Scale (OOAS) focuses on competence, concerns,
and readiness to act for healthcare professionals, patients, and family members (Williams
et al., 2013). This scale took 15 minutes to complete and has an alpha coefficient of 0.90
(Williams et al., 2013). To assess content validity, the scores of addiction professionals
were compared to family members of opioid users. The professionals had significantly
higher scores. The OOAS was compared to the General Self-efficacy Scale but was not
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found to be correlated (Williams et al., 2013). The OOAS scale and scoring can be found
in Appendix I.
The Opioid Overdose Knowledge Scale (OOKS) discusses risk factors, signs and
symptoms, immediate actions, naloxone effect and administration, adverse effects, and
post-naloxone cares (Williams et al., 2013). The questionnaire took 10 minutes and for
each correct answer, set point values were rewarded. The OOKS has an alpha coefficient
of 0.83 and was compared to the evidence-based and statistically significant Brief
Overdose Recognition and Response Assessment (BORRA) (Williams et al., 2013). The
OOKS and the BORRA were positively correlated as a whole and on each sub-topic. The
OOKS scale and scoring can be found in Appendix J. See Appendix K for permission to
use OOAS and OOKS scales.
Project Procedure
The DNP Project Coordinator was solely responsible for organization, design, and
implementation of this DNP Project through coordination of multiple agencies and
establishing evidence-based processes to assess competency and efficacy. First, the DNP
Project Coordinator gained approval from the DNP Project site and the university. Next,
before receiving naloxone education, homeless shelter staff completed the OOAS,
OOKS, and demographics survey with their assigned anonymous number. PowerPoint
education using the tool above was provided with an in-person educator from the
Statewide Naloxone Project committee.
After the PowerPoint and in-person demonstration by the State Naloxone
Educator, competency check-offs occurred individually. The facility was given two
naloxone kits that were to remain in the facility. Staff members were required to
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demonstrate appropriate assessment of an opioid overdosing individual, proper
administration of intranasal naloxone, and appropriate positioning or cardiopulmonary
resuscitation of the individual who overdosed. This demonstration was done for the State
Naloxone Educator and the DNP Project Coordinator. The staff completed a posteducation OOKS and OOAS that corresponded with their anonymous number.
The DNP Project Coordinator assured inclusion of the homeless shelter in grant
funding for naloxone. Naloxone was provided after a Hold Harmless Agreement was
signed by the facility director through the Federal Grant Funds that were received by the
state’s Naloxone Project. A Hold Harmless Agreement is a legal contract that releases
both parties of any legal liability for injuries or damages endured by the organization
signing the contract (E. Taylor, personal communication, July 30, 2020; Department of
Health, 2020). The purpose of utilizing this approach was to secure grant-funded, longterm naloxone supplies for the shelter.
If staff members witnessed a possible overdose, according to protocol established
by the DNP Project Coordinator, the staff would first contact EMS via telephone and the
shelter manager on duty in person. The shelter manager was in charge of carrying
naloxone on his or her person during his or her shift. Staff was reminded to survey the
scene, not touch any drug paraphernalia, and not leave the individual alone thus working
as a team. If naloxone was administered and the shelter resident woke, the resident could
be agitated and the safety of both the staff and the shelter resident was of utmost
importance. The arrival of law enforcement or EMS, as first responders, required the staff
to quickly and accurately report event circumstances. Staff were required to remove
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personal protective equipment and dispose of it in a tied garbage bag, prior to performing
hand hygiene.
Three months after the education and training session, the DNP Project
Coordinator utilized an anonymous survey to assess naloxone usage. After the 3-month
tracking period, a repeat OOAS and OOKS were sent out to staff to assess their retention
of information. The DNP Project Coordinator then compared pre-, immediate-post, and
3-month post-education data for the sample as a whole.
Ethical Considerations
Maintaining an ethical environment was of utmost importance for the DNP
Project. Before the mandatory site-wide education, participants utilized an anonymous
number as their identifier. This identifier consisted of two letters; the first letter was the
first letter of the individual’s father’s first name, the second letter was the individual’s
middle initial, followed by a four-digit code that coincided with the individual’s birth
year.
Paper copies of surveys were stored in the site manager’s office in a locked filing
cabinet. This office was also locked at all times. Names and personal information were
not collected. Information will be maintained with the DNP Project Coordinator for 5
years via an encrypted USB drive. After six years, the staff member surveys will be
shredded. The DNP Project site does not have a time or location requirement for saving
or storing employee education information.
Individuals who could endure intranasal naloxone treatment have their ethical
rights maintained as the treatment they receive is routine, emergency medical, and
evidence-based standards of care. The DNP Project was evaluated against the DNP
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Project Coordinator’s university institution review board after the proposal and according
to an algorithm put forth by the Human Subjects Committee, the DNP Project does not
meet federal and university definition of human subjects research as seen in Appendix A.
Results
Two data sets were collected for this DNP Project. The first included the number
of naloxone refills requested by the facility in 3 months. No refills were requested during
the intervention period. Additionally, through an anonymous survey, staff members
reported not using naloxone in the 3-month intervention period.
The DNP Project Coordinator and a statistician performed a statistical analysis of
the data using a paired-t test. The significance level was set for a=0.05. For the OOAS,
the average pre-education was 84.71 (SD +/- 7.42), the average immediate post-education
came to 90.79 (SD +/- 10.82), and the average 3-month post was 91.86 (SD +/- 11.39).
Pre-education, post-education, and 3-month post-education average scores can be found
in Appendix L for individual components of the OOAS. There was no statistical
significance for the difference between the average pre-education and immediate posteducation (p= 0.051); between immediate post-education and 3-month post-education
(p=0.439); and between pre-education and 3-month education (p=0.062). Individual
components of the OOAS that were statistically significant included competency for both
pre-education to immediate post-education (p=0.00075) and pre-education to 3-month
post-education (p=0.017).
The average group scores for the OOKS are as follows: pre-education of 28.5 (SD
+/- 6.56), immediate post-education of 32.86 (SD +/- 4.72), and 3-month OOKS
education was 31.43 (SD +/- 0.98). Average pre-education to immediate post-education
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scores showed statistical significance (p= 0.046). Average immediate post-education to 3month post-education scores did not show statistical significance (p=0.12). Average preeducation to 3-month post-education did not show statistical significance (p=0.26). The
risk and naloxone questions showed statistical significance (p= 0.03; p=0.02) between
pre-education and immediate-post education. All other individual components did not
show statistical significance. The average score for the individual OOKS components can
be seen in Appendix M.
The DNP Project Coordinator and a statistician performed a statistical analysis of
the data as a whole using a repeated measures analysis with linear mixed models.
Through this method, the OOAS changes were not statistically significant (p=0.14).
Additionally, OOKS changes were not statistically significant (p=0.25).
Discussion
Implications for Practice
Clinical Significance
The surveys as a whole did not have a statistically significant change in scores.
An expected outcome was the increase in survey scores, thus an increase in knowledge.
The scores showed an increase in knowledge from baseline and sustained scores, greater
than pre-testing, at the 3-month mark. Additionally, this DNP Project’s purpose was
equipping staff with valuable opioid overdose and treatment knowledge. Having a
standardized naloxone protocol for this facility bolstered staff confidence in helping those
suffering from opioid overdose and provided a safeguard for the residents that they serve
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Impact on the Organization, Policy, and Quality of Healthcare
This DNP Project had the potential to equip high-risk environments with
lifesaving treatment. There is the potential to improve the teaching methods based on
feedback from surveys. Because naloxone was not readily available to the public, this
intervention helped the organization approach the care of an underserved and vulnerable
population. Additionally, this policy influenced other high-risk organizations in the
community to adopt this program, or similar naloxone teaching programs. If more
community organizations adopt similar programs, the rate of fatal opioid overdoses in the
community; could drastically decrease in this at-risk population.
Finances and Sustainability
Financial costs for the organization included reimbursement of staff’s paid
education time. Facility staff were reimbursed for their participation based on their usual
hourly wage; staff were reimbursed for all educational training as this was facility
protocol (M. Shields, personal conversation, October 8, 2020). Financial costs for the
community and the individual are difficult to quantify, as individual lives were being
saved. The DNP Project was eligible for grant funding because part of the intervention
utilized a program associated with the Department of Health. Funding for printing and
paper materials was by the DNP Project Coordinator.
Scheirer and Dearing (2011) discuss that in public health, sustainability is a major
barrier. Structural measures support sustainability; there were many medical personnel
infiltrated in the organization (Agency for Healthcare Research, 2015). One DNP Project
member, the Safety Coordinator, focused solely on the safety of staff and residents.
Outcome measures that attributed to sustainability were the utilization of naloxone and 3-
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month follow-up surveys (Agency for Healthcare Research, 2015). After the pilot
program, the organization was included in grant funding for naloxone, as part of the
Statewide Naloxone Project. Naloxone was provided by the State Naloxone Educator.
Limitations
The statistical power and results do not allow for generalizability of the DNP
Project due to small sample size. The method of collection for the OOKS and OOAS may
be less statistically powerful than other forms of measurement and may not prevent bias.
However, other measurement techniques were not utilized for the data sample. This DNP
Project was completed in a location that voluntarily agreed to have the education and
process implemented. Another barrier includes the underreporting of reversals. Initially,
the sample size was 30 participants, including administration and volunteers, however,
due to limited room capacity, the sample size was adjusted to include only frontline
persons with likelihood for opioid overdose encounters.
Recommendations for Further Practice
A longer collection period of data may offer greater significance for monitoring
naloxone refills. Future DNP Projects and studies could delve into specifics, feelings, and
successes of opioid reversals by staff. It would be beneficial from a communityperspective, to institute a public network of take-home naloxone organizations. This
would allow better access to naloxone and increase the public’s awareness of available
resources. Allowing for survey completion via electronic survey or paper copy would
improve sample size.
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Conclusion
Utilizing Barrett’s Theory of Power as Knowing Participation, the Johns Hopkins
Evidence-Based Practice model, and Peplau’s theory of nurse-client relationship was
essential to the success of this DNP Project. The primary outcome of the DNP Project
was to quantify the number of opioid reversals by keeping track of refills requested by
the facility. Secondary outcomes included improved OOAS and OOKS scores by
homeless shelter staff members.
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Appendix E
Demographic Survey
Demographic Survey
The following information will remain anonymous. Please circle your answer, your honesty is
appreciated.
• What gender do you identify with:
o Male
o Female
o Prefer not to answer
• Select the group that your age falls into:
o 0-18
o 19-30
o 31-45
o 46-65
o 65+
o Prefer not to answer
• Please select the category that closely resembles your experience with the homeless
population
o Less than 1 year
o 1-4 years
o 5-10 years
o 10-15 years
o 15+ years
• Please select the category that exhibits your level of medical training:
o I have previously or currently have a license in healthcare
o I have been trained in basic life support (cardiopulmonary resuscitation)
o I have no prior medical training
o Prefer not to answer
• Please select the category that indicates the highest level of education you have received:
o Some high school
o High school diploma/GED
o Trade school
o Associate degree
o Bachelor Degree
o Master Degree
o Doctorate Degree
o Prefer not to answer
• With the Bishop Dudley Hospitality House, do you:
o Volunteer
o Work to live at the shelter
o Part-time employee
o Full-time employee
o Prefer not to answer

Appendix F
Demographic Breakdown
Figure 1 shows that more staff members were full-time. This survey determined
that six were trained in basic life support and eight have no prior medical or life support
training. Medical training experience can be seen in Figure 2. Of individuals who filled
out the pre-survey, one individual was between 0-18 years old, seven were between 1930 years old, one was between 31-45 years old, four were between 46-65 years old, and
one was older than 65 years. Age breakdown can be seen in Figure 3, with the majority of
participants between 19-30 years old. Figure 4 depicts the breakdown of genders for the
pre-survey. Nine females and five males participated in the survey.

Figure 1

Figure 2

Employment Status

Medical Training

3

6
8

11

Part-Time

Full-Time

BLS/CPR

No training

Figure 3

Figure 4

Age

Gender

11

5

4
7

9

1
0-18

19-30

31-45

46-65

65+

Male

Figure 5
Experience
1

2

3
<1 year
5-10 years
15+ years

8

1-4 years
10-15 years

Female
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THE NALOXONE PROJECT

WHAT BRINGS US TOGETHER?

SOUTH DAKOTA STATE TARGETED RESPONSE TO THE OPIOID CRISIS

Nationwide opioid epidemic
The Impact Realized in South Dakota

NALOXONE PROJECT STAFF AND TRAINERS

OPIOID GRANTS

• Tom Martinec, Deputy Secretary Department of Health
• Amy Iversen-Pollreisz, Deputy Secretary Department of Social Services
• Tiffany Wolfgang, Director, Division of Behavioral Health

Department of Health
Department of Social Services

• Marty Link
•

Assistant Administrator, Office of Rural Health

•

Director of EMS and Trauma

• Eugene Taylor

Shawn Fischer

•

DOH Consultant—Eastern SD Lead Educator

DOH Consultant—Western SD Lead Educator

•

Critical Care Paramedic

Critical Care Paramedic

THE DEPARTMENT OF HEALTH
CDC FUNDED OPIOID ABUSE GRANT

THE DEPARTMENT OF SOCIAL SERVICES
CDC FUNDED OPIOID ABUSE GRANT

Prescription Drug Overdose: Data-Driven Prevention Initiative planning grant

Grant Purpose
• To support and build efforts to track and understand the full impact of opioid use and abuse in SD
•

conduct a needs assessment;

•

complete a strategy plan to identify needs and strengthen South Dakota’s capacity to prevent misuse/abuse of
opioids; and

•

develop a data strategy to enhance and integrate current surveillance efforts for more accurate, timely data.

•

State Targeted Response to the Opioid Crisis Grant (Opioid STR).

The purpose of the grant program is to:
(a) Increase access to treatment;
(b) Supplement current opioid activities; and
(c) Support a comprehensive response to the opioid epidemic

NALOXONE TRAINING AND DISTRIBUTION

NALOXONE TEAM MEMBERS
Department of Social Services

• Office of Rural Health—Lead Agency

Department of Health

• Purpose:

Office of Rural Health, EMS Program

• Train and Equip First Responders on Naloxone Use
• Hospital

Project Super-Trainers

• EMS

Evaluation Team

• Law Enforcement

Data Collection

• Training through Eight Regional Sessions
• Initial goal of training 500 responders between October and December of 2017

Project Medical Director

SD DOH VITAL STATISTICS:
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CDC DEATH DATA BY STATE

Opioid Related Deaths

2015 Age-Adjusted Drug Overdose Death Rates per 100,000 by State
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DRUG-RELATED OVERDOSE DEFINED
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34-20A-109. Definitions related to reporting person in need of emergency assistance for drugrelated overdose. Terms used in §§ 34-20A-110 to 34-20A-113, inclusive, mean:

•

(1) "Drug-related overdose," an acute condition, including mania, hysteria, extreme physical
illness, coma, or death resulting from the consumption or use of a controlled substance, or another
substance with which a controlled substance was combined, and that a person would reasonably
believe to be a drug overdose that requires medical assistance.
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SOUTH DAKOTA STATUTES

•

34-20A-99. Opioid antagonist defined. For the purposes of §§ 34-20A-98 to 34-20A-103, inclusive, the term, opioid antagonist, means
naloxone hydrochloride or any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the
treatment of drug overdose.

34-20A-101. Training of first responders. Each first responder authorized to administer an opioid antagonist shall be
trained in the symptoms of an opiate overdose; the protocols and procedures for administration of an opioid antagonist; the
symptoms of adverse responses to an opioid antagonist, and protocols and procedures to stabilize the patient if an adverse
response occurs; and the procedures for storage, transport, and security of the opioid antagonist. The training shall comply
with the criteria established pursuant to § 34-20A-102, and may be provided by the employer of first responders at the
employer's discretion.

•

Source: SL 2015, ch 179, § 4.

Source: SL 2015, ch 179, § 2.

•

34-20A-102. Promulgation of rules for training, possession, and administration of opioid antagonists. The Board of
Medical and Osteopathic Examiners shall promulgate rules, pursuant to chapter 1-26, establishing:

•

34-20A-98. Possession and administration of opioid antagonists by first responders. Any first responder trained in compliance with § 34-20A101 and acting under a standing order issued by a physician licensed pursuant to chapter 36-4 may possess and administer opioid antagonists
to a person exhibiting symptoms of an opiate overdose.

•

Source: SL 2015, ch 179, § 1.

•

•
•
•

SOUTH DAKOTA STATUES

34-20A-100. First responder defined. For the purposes of §§ 34-20A-98 to 34-20A-103, inclusive, the term, first responder, includes:
(1)

A law enforcement officer as defined by subdivision 22-1-2(22);

•

(2)

A driver and attendant responding to an emergency call as part of an ambulance service licensed pursuant to chapter 34-11; and

•

(3)

A firefighter.

Source: SL 2015, ch 179, § 3.

•
•

(1)

The criteria for training a first responder to comply with the provisions of § 34-20A-101; and

(2) The requirements for a physician's issuance of a standing order to a first responder authorizing a prescription
for the first responder's possession of an opioid antagonist and the protocols and procedures to be followed in administering
an opioid antagonist.
Source: SL 2015, ch 179, § 5.

SOUTH DAKOTA IMMUNITY STATUES
•

34-20A-103. Immunity from civil liability for injuries or death associated with administration of opioid
antagonists. A physician who issues a standing order under the rules established pursuant to § 34-20A-102, a
first responder acting under a standing order who administers an opioid antagonist in good faith compliance
with the protocols for administering an opioid antagonist, and the first responder's employer, are not civilly
liable for injuries, and may not be held to pay damages to any person, or the person's parents, siblings,
children, estate, heirs, or devisees, for injuries or death associated with the administration of an opioid
antagonist.

• Source: SL 2015, ch 179, § 6.
•

34-20A-104. Possession and administration of opioid antagonists by person close to person at risk of
overdose. A person who is a family member, friend, or other close third party to a person at risk for an opioidrelated drug overdose may be prescribed, possess, distribute, or administer an opioid antagonist that is
prescribed, dispensed, or distributed by a licensed health care professional directly or by standing order
pursuant to §§ 34-20A-104 to 34-20A-108, inclusive.

SOUTH DAKOTA IMMUNITY—CONTINUED
•

34-20A-105. Prescription for opioid antagonist. A licensed health care professional may, directly or
by standing order, prescribe an opioid antagonist to a person at risk of experiencing an opioid-related
overdose, or prescribe to a family member, friend, or other close third party person the health care
practitioner reasonably believes to be in a position to assist a person at risk of experiencing an opioidrelated overdose.

• Source: SL 2016, ch 174, § 2.
•

34-20A-106. Health care professional immunity from liability. A health care professional who is
authorized to prescribe or dispense an opioid antagonist is not subject to any disciplinary action or civil
or criminal liability for the prescribing or dispensing of an opioid antagonist to a person whom the
health care professional reasonably believes may be in a position to assist or administer the opioid
antagonist to a person at risk for an opioid-related drug overdose.

• Source: SL 2016, ch 174, § 1.

• Source: SL 2016, ch 174, § 3.

SOUTH DAKOTA IMMUNITY—CONTINUED

ONE TIME IMMUNITY—NON FIRST RESPONDERS

•

•
•
•

34-20A-110. Immunity from arrest or prosecution for reporting person in need of emergency medical assistance for drug-related overdose. No person may be
arrested or prosecuted for any misdemeanor or felony offense of possession, inhalation, ingestion, or otherwise taking into the body any controlled drug or substance if
that person contacts any law enforcement or emergency medical services and reports that a person is in need of emergency medical assistance as the result of a drugrelated overdose. A person qualifies for the immunities provided in §§ 34-20A-109 to 34-20A-113, inclusive, only if:
(1)

The evidence for the charge or prosecution was obtained as a result of the person seeking medical assistance for another person;

(2)

The person seeks medical assistance for another person who is in need of medical assistance for an immediate health or safety concern; and

(3)

The person seeking medical assistance for another person remains on the scene and cooperates with medical assistance and law enforcement personnel.

Source: SL 2017, ch 154, § 2.
•

34-20A-111. Immunity from arrest or prosecution for reporting one's own need for emergency medical assistance for drug-related overdose. A person who
experiences a drug-related overdose and is in need of medical assistance may not be arrested, charged, or prosecuted for any misdemeanor or felony offense of
possession, inhalation, ingestion, or otherwise taking into the body any controlled drug or substance if that person contacts law enforcement or emergency medical
services and reports that he or she is in need of medical assistance as the result of a drug-related overdose. A person qualifies for the immunities provided in this section
only if the evidence for the charge or prosecution was obtained as a result of the drug-related overdose and the need for medical assistance.

•

Source: SL 2017, ch 154, § 3.

•

34-20A-113. One-time immunity. Any person seeking medical assistance or who reports a
person is in need of medical assistance shall only qualify once for immunity under §§ 34-20A109 to 34-20A-112, inclusive.

• Source: SL 2017, ch 154, § 5.

• Understand the overdose crisis

First Responder
Overdose Response
Training

LEARNING
OBJECTIVES

• Know how opioids work and
overdose risk factors
• Recognize an opioid overdose
• Respond to opioid overdose

AMERICA LEADS THE WORLD IN DRUG OVERDOSE
DEATHS — BY A LOT

THE OPIOID EPIDEMIC, EXPLAINED

• America has about 4 percent of the world’s
population — but about 27 percent of the
world’s drug overdose deaths.

• In 2015, more Americans died of drug overdoses than in any other
year on record — more than 52,000 deaths in just one year.

• Americans are relatively wealthy, so they
can afford to buy drugs.

• That’s higher than the more than 38,000 who died in car crashes,
the more than 36,000 who died from gun violence, and the more
than 43,000 who died due to HIV/AIDS during that epidemic’s peak
in 1995.

• In 1999, fewer than 17,000 people died
from drug overdoses.
• In 2015, that grew to more than 52,000

HOW OVERDOSE OCCURS

HOW DO OPIOIDS AFFECT
BREATHING?
Opioid
Opioid Receptors

•

Breathing Slows

• Breathing Stops

• Heart Stops

•Death

• Lack of oxygen may
cause brain damage

WHICH MEDICATIONS
ARE CONSIDERED OPIOIDS?

Opioids

Natural Opiates

Semi-Synthetic
Opiates

opium
morphine
codeine

heroin
hydromorphone
hydrocodone
oxycodone

Fully Synthetic
Opioids

• Morphine is often used before and after
surgical procedures to alleviate severe pain.
It is often used as a palliative drug for endstage terminal cancer.

• Codeine is often prescribed for mild pain,
can be used to relieve coughs and severe
diarrhea.
• Oxycodone (OxyContin, Percocet)

fentanyl
methadone

The term opiate is often used as a synonym for opioid, however
the term opiate refers to just those opioids derived from the
poppy plant either natural or semi-synthetic

• Hydrocodone products are most commonly
prescribed for a variety of painful
conditions, including dental and injuryrelated pain.

• Fentanyl

WHAT ARE OPIOIDS/OPIATES?
•

Medications that relieve
pain

•

Attach to the opioid
receptors in the brain and
reduce the intensity of
pain signals reaching the
brain.

HOW HAS THIS HAPPENED ?
• Back in the 1990s, doctors were persuaded to treat pain as a serious medical issue. There’s a good
reason for that: About 100 million US adults suffer from chronic pain

• Pharmaceutical companies took advantage of this concern. Through a big marketing campaign, they got
doctors to prescribe products like OxyContin and Percocet in droves — even though the evidence for
opioids treating long-term, chronic pain is very weak (despite their effectiveness for short-term, acute
pain), while the evidence that opioids cause harm in the long term is very strong.

• Painkillers proliferated, landing in the hands of not just patients but also teens rummaging through their
parents’ medicine cabinets, other family members and friends of patients, and the black market.

• As a result, opioid overdose deaths trended upward — sometimes involving opioids alone, other times
involving drugs like alcohol and benzodiazepines (typically prescribed to relieve anxiety). By 2015,
opioid overdose deaths totaled more than 33,000 — close to two-thirds of all drug overdose deaths.

HOW ARE WE TRYING TO
CORRECT THIS?
• Seeing the rise in opioid misuse and deaths, officials have cracked down on
prescriptions painkillers.

SOUTH DAKOTA
• In 2016, South Dakota medical doctors prescribed supplies of painkillers that totaled more
than 3.6 million days of Hydrocodone; more than 3.2 million days of Tramadol; more than 1
million days of Oxycodone; and nearly 700,000 days of Oxycodone with acetaminophen.
• Enough doses of opiates were prescribed to South Dakotans in 2015 to medicate

• Physicians are now being told to give more thought to their prescriptions.

every SD adult around-the-clock for 19 straight days
• Between 2004-2011: 82 Opioid Deaths (approximately 10 per year)
• 2013: 17 Opioid Deaths

• Yet many people who lost access to painkillers prescriptions are still addicted.

• 2014: 16 Opioid Deaths
• Prescription Drug Monitoring Programs (PDMPs)

• So some who could no longer obtain prescribed painkillers turned to cheaper,
more potent opioids: heroin and fentanyl, a synthetic opioid that’s often
manufactured illegally for nonmedical uses.

PRESCRIPTION DRUG
MONITORING PROGRAM

PRESCRIPTION DRUG
MONITORING PROGRAM

NATIONAL & REGIONAL DRUG THREAT

PRESCRIPTION OPIOID SALES, DEATHS
AND TREATMENT: 2000 - 2015

FENTANYL
Fentanyl: a synthetic short-acting opioid; 40-50x more
potent than pure heroin
Illicitly manufactured fentanyl is sold in the illicit

First on scene of an overdose

WHY LAW
ENFORCEMENT

Frequent interaction with high risk
population
With the right tools, police can make
a public health impact

market often mixed with heroin and/or cocaine
as a combination product — with or without the
user’s knowledge — to increase its euphoric effects

Build bridges to active users and their
social networks

Fentanyl-related overdoses can be reversed with naloxone, however a higher dose or
multiple number of doses per overdose event may be required due to its high potency

Overdose is a true crisis and police
can help

RECOGNIZE OVERDOSE
SIGNS/SYMPTOMS

JUST HIGH/OVERMEDICATED VS OVERDOSE

• If a person is not breathing or is struggling to breath: call out their name and rub knuckles of
a closed fist over the sternum (Sternum Rub)

Just High/Overmedicated

• Signs of drug use ?
• Pills, drugs, needles, cookers

• Small Pupils
• Drowsy, but arousable
•

• Look for overdose

Responds to sternal rub

• Speech is slurred

• Slow or absent breathing
• Gasping for breath or a snoring sound

• Drowsy, but breathing
•

8 or more times per minute

• Pinpoint Pupils

Overdose
• Small Pupils
• Not arousable
•

No response to sternal rub

• Not speaking
• Breathing slow or not at all
•

< 8 times per minute

•

May hear choking sounds or a gurgling/snoring
noise

•

Blue/gray lips and fingertips

• Blue/Gray lips and nails

Stimulate and observe
• Ensure EMS is en route/activated

Rescue breathe +
administer Naloxone

WHAT IS AN OPIOID OVERDOSE ?

REVOLVING DOOR???
• As it is for tobacco and weight loss, it takes multiple attempts before
achieving success
• By definition, addiction is a chronic condition where people make risky
choices despite negative consequences
• With time, treatment works - people get better
• With treatment, crime is less common and therefore they interact with police
less often
• Law enforcement because its law enforcement is more likely to see the relapses
than recovery

MEDICATIONS FOR OPIOID OVERDOSE AND
TREATMENT
• Narcan = Naloxone
• Reverses opioid overdoses
• Short and Fast acting opioid blockers
• Vivitrol = Naltrexone
• Treatment for opioid and alcohol
addiction

• No Street Value because they
cause withdrawal symptoms

MEDICATIONS FOR OPIOID OVERDOSE AND
TREATMENT
UPDATED OPIOIDASSOCIATED LIFE
THREATENING ALGORITHM

• Surboxone = Buprenorphine + Naloxone
•

Treatment of opioid addiction

•

The naloxone is added to discourage injecting or
sniffing

• Subutex = Buprenorphine Only
•

Treatment of opioid in pregnant women

• These do have Street Value
because they can relieve
withdrawal symptoms

American Heart Association Guideline
October 2015

• Methadone aka Dolophine and Methadose
•

Treatment of opioid addiction or pain

AFTER ADMINISTERING NALOXONE
• Continue to provide rescue
breathing with 1 ventilation every 5
seconds until EMS arrives

• After 3-5 minutes, if the patient is
still unresponsive with slow or no
breathing, administer another dose
of Naloxone

IF VICTIM IS BREATHING, BUT UNRESPONSIVE
PLACE IN RECOVERY POSITION

WHAT IS NARCAN (NALOXONE) ?
• Narcan knocks the opioids off the
opioid receptors, blocking opioids
from the opioid
• Temporarily takes away the “high”,
giving the person the chance to
breathe
• Narcan works in 1 to 3 minutes and
last 60 minutes
• Narcan can neither be abused nor
cause an overdose effect
• Only contraindication is known sensitivity,
which is extremely rare

• Too much Narcan can cause
withdrawal symptoms such as:
• Nausea/Vomiting Muscle Discomfort
• Diarrhea

Disorientation

• Chills

Combativeness

NALOXONE REVERSING OVERDOSE

CONSIDERATIONS TO ALWAYS REMEMBER

HOW DOES NARCAN
AFFECT OVERDOSE?

ADMINISTERING NALOXONE

• Always keep the scene safety as your top priority
• Make sure EMS has been dispatched and keep them updated
• If the patient does not have a pulse, immediately begin CPR along with administration of
Narcan
• If the patient is gasping or is not breathing, initiate CPR/Rescue breathing as necessary in
addition to Naloxone administration
• Naloxone is quick (1-3 minutes) and typically lasts 60 minutes

NASAL SPRAY NALOXONE

REMEMBER “FOUR RIGHTS”
FOR MEDICATION ADMINISTRATION

EXPECTED RESPONSE
FROM NALOXONE
• 1. Gradually improves breathing and becomes responsive with 3 – 5 minutes

• Right Patient (Opioid Overdose)
• Right Medication (Naloxone – Check for Clarity)

• 2. Immediately improves breathing, responsive and is in withdrawal
• 3. Starts breathing with 3-5 minutes but may remain unconscious

• Right Date (Check Expiration)
• Right Dose (Spray entire contacts into nostril)

• 4. Does not respond to first dose and Naloxone must be repeated in 3 – 5 minutes (Continue
to provide Rescue Breaths)
• 5. No response to multiple doses of Naloxone

NALOXONE STORAGE

QUESTIONS AND ANSWERS
• Will Naloxone work on an alcohol overdose ?
• No. Naloxone only works on opioids

• 59 – 77 degrees Fahrenheit

• What if it is a crack/cocaine or speed/methamphetamine overdose ?
• No. Naloxone only works on opioids

• Replace prior to expiration date

• What is the risk period for an overdose to reoccur after giving Naloxone ?
• Depends on how long acting the opioid is and how much they took
• If the person isn’t overdosing and I give Naloxone will it hurt the person ?
• No. If in doubt give Naloxone

WHAT IF A PERSON REFUSES CARE AND
TRANSPORT AFTER NALOXONE IS
ADMINISTERED?

SPECIAL THANKS

• Inform the person of the risk of re-overdosing
• Inform the person naloxone is only temporary
• If person still refuses consider the mechanism of injury or Illness
• Do you believe he/she can refuse treatment with a sound mind
and clear understanding of the circumstances? Remember they
just overdosed!
• If no, the person can not refuse treatment

To the Massachusetts Office of EMS
For their assistance and use of the Opioid content.

Appendix H
Naloxone Protocol
1. Dial 911.
2. Alert the shelter manager on duty.
3. Survey the scene for safety.
a. Do not touch any paraphernalia.
b. Do not leave the individual alone.
4. Put on gloves and a mask with a face shield
5. Move bystanders from the area and provide privacy with blankets.
6. Administer naloxone if the resident has one or more of the following symptoms
a. Small, constricted pupils
b. Falling asleep or unable to wake up
c. Shallow, slow breathing
d. Choking or gurgling sounds
e. Limp body
f. Pale, blue, cold skin
7. Place resident in the recovery position, on their side if they wake up with naloxone.
8. If no improvement in resident’s symptoms, begin cardiopulmonary resuscitation.
9. Notify first responders of events.
10. Remove personal protective equipment and dispose in a tied garbage bag.
11. Wash hands and face thoroughly.

Appendix I
Opioid Overdose Attitudes Scale and Scoring

Appendix J
Opioid Overdose Knowledge Scale and Scoring

Appendix K
OOAS and OOKS Permission to Use

Appendix L
OOAS Average Score Breakdown
Quiz Component

Pre-

Immediate Post-

Three Month Post-

Competence

23.07

30.66

29.43

Concern

29.50

30.17

30.71

Readiness

32.14

30.08

31.71

Quiz Component

Pre-Immediate

Pre vs. 3 months

Immediate vs. 3
months

Competence

p= 0.00075

p=0.017

p= 0.31

Concern

p=0.35

p= 0.38

p=0.5

Readiness

p=0.09

p=0.37

p=0.25

Appendix M
OOKS Average Score Breakdown
Quiz Component

Pre-

Immediate Post-

Three-Month Post-

Risk

7.29 (SD +/- 2.70)

8.64 (SD +/- 0.75)

8.76 ( SD +/- 0.76)

Signs

7.64 (SD +/- 1.78)

7.21 (SD +/- 1.05)

7.57 (SD +/-0.53)

Action

9.14 (SD +/- 2.28)

9.93 (SD +/- 0.92)

10.43 (SD +/- 0.53)

Naloxone

4.43 (SD +/- 2.82)

7.07 (SD +/- 3.85)

4.71 (SD +/- 0.95)

Quiz Component

Pre vs. Immediate

Pre vs. 3-Month

Immediate vs. 3Month

Risk

p=0.03

p=0.13

p=0.35

Signs

p=0.34

p=0.37

p=0.39

Action

p=0.13

P=0.13

p=0.10

Naloxone

p= 0.02

p=0.41

p= 0.08

